Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer

for
Metastatic Cancer, Oligoprogressive
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT04989725

Phase 2, Recruiting

BostonGene-Integrated Genomic Registry (BIGR)

for
Malignancy
Location: Waltham MA
Sponsor: BostonGene

Sex: All

Age: 18+

Code: NCT04991922

Recruiting

Tumor Related Epilepsy

for
Epilepsy, Cancer, Brain Neoplasm
Location: Bethesda MD
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 8 - 70+

Code: NCT02639325

Recruiting

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

for
Malignant Neoplasm
Location: Fairfax VA, Houston TX, San Antonio TX
Sponsor: Tyligand Pharmaceuticals (Suzhou) Limited

Sex: All

Age: 18 - 70+

Code: NCT06385925

Phase 1, Phase 2, Recruiting

Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer

for
NSCLC, HNSCC, Melanoma, Metastatic Cancer, Advanced Solid Tumor,
Location: Pittsburgh PA, Irvine CA
Sponsor: CJ Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT05877430

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A New Psychotherapy Intervention for Older Cancer Patients

for
Cancer
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 70+

Code: NCT04452825

Recruiting

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

for
Carcinomas (Including Squamous Cell and Adenocarcinoma),
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT00349830

Recruiting

Positron Emission Tomography (PET) Imaging of Thrombosis

for
Atrial Fibrillation, COVID-19, Cancer, Thrombosis
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70+

Code: NCT03830320

Phase 1, Recruiting

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

for
Neoplasms, Neoplasm Metastasis, Non-Small-Cell Lung Cancer
Location: Boston MA, Canton OH, Detroit MI
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.

Sex: All

Age: 18+

Code: NCT03797391

Phase 1, Phase 2, Recruiting

Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence

for
Solid Tumor
Location: Orange CA, Long Beach CA
Sponsor: Miller Children's & Women's Hospital Long Beach

Sex: All

Age: 1 - 31

Code: NCT02446431

Early Phase 1, Recruiting

A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change

for
Metastatic Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05010031

Phase 2, Recruiting

Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol

for
Solid Tumor
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05390827

Recruiting

Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer

for
Pediatric Cancer, Oncology, Disruptive Behavior
Location: St. Petersburg FL
Sponsor: Johns Hopkins All Children's Hospital

Sex: All

Age: 0+

Code: NCT06346782

Recruiting

Study of Personalized Cancer Therapy to Determine Response and Toxicity

for
Cancer
Location: Rancho Mirage CA, San Diego CA, La Jolla CA
Sponsor: Shu Mei Kato

Sex: All

Age: 7+

Code: NCT02478931

Recruiting

Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS

for
Advanced Solid Tumors
Location: Cincinnati OH, Houston TX, Salt Lake City UT
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.

Sex: All

Age: 18+

Code: NCT06096974

Phase 1, Recruiting

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

for
Childhood Malignant Solid Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 0 - 17

Code: NCT06915727

Phase 3, Recruiting

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

for
Solid Tumor, Adult
Location: Boston MA, New Haven CT, Orlando FL, Birmingham AL,
Sponsor: Corbus Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06265727

Phase 1, Phase 2, Recruiting

Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

for
Cancer, Advanced Cancer, Advanced Solid Tumor,
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT05166694

Recruiting

A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors

for
Mesothelioma, Epithelioid Hemangioendothelioma(EHE),
Location: Houston TX
Sponsor: BridGene Biosciences Inc.

Sex: All

Age: 18+

Code: NCT06452160

Phase 1, Recruiting

First In Human Study of CX-801 in Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Pittsburgh PA, Nashville TN, Fort Worth TX,
Sponsor: CytomX Therapeutics

Sex: All

Age: 18+

Code: NCT06462794

Phase 1, Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial